TTrialPathMatch Me to Trials
← Back to trials
RecruitingAmblyopia

Amblyopia Treatment for Children Aged 8 to 12 Years

Eligible age

8–12 yrs

Accepts

All genders

Locations

1 state

Healthy volunteers

Yes

See if you qualify for this study

Answer a few quick questions about your location and health. Takes about a minute.

Check my eligibility →

About this study

This study is being done to assess the effect of at-home amblyopia treatment with Curesight™ for children aged 8 to 12 years. Curesight™ allows you to stream any videos on a computer screen at home but the amblyopic eye will see the entire screen clearly while part of the image will be blurred for the other eye. There is already a pivotal clinical trial showing that this treatment is effective for young children and Curesight™ has been cleared for use as an amblyopia treatment by the FDA for children as young as 4 years.

Sponsor: Retina Foundation of the Southwest

You may qualify if…

  • ✓ Female and male children with amblyopia age 8-12 years inclusive
  • ✓ Amblyopic eye visual acuity ≤ 1.0 logMar (20/32-20/200)
  • ✓ Interocular difference in visual acuity of 0.3 logMAR or more
  • ✓ Anisometropia or strabismus corrected to \<5 pd
  • ✓ Wearing glasses (if needed) ≥8 weeks
  • ✓ No longer using standard-of-care treatments for amblyopia
  • ✓ Informed consent

You may not qualify if…

  • ✕ Prematurity \>8 weeks
  • ✕ Coexisting ocular or systemic disease
  • ✕ Developmental delay
  • ✕ History of light-induced epilepsy
  • ✕ Eye conditions that interfere with eye tracking (nystagmus, wearing RGP contact lenses, paralysis of the extra ocular muscles or any neurological condition that restricts eye movements, ptosis that covers the pupil)

Where it's recruiting

Texas

Dallas

Source: ClinicalTrials.gov · NCT07281742 · last updated 2025-12-15